In clinical trials, Semaglutide GLP-1 has been studied for different durations, ranging from 16 to 68 weeks, with varying dosages
Other therapies were linked to increased adverse events such as stroke [11], hyperkalemia [13,15], hypotension [13], acute kidney injury (AKI) [15], and major adverse cardiovascular events (MACE) [14]
Plus, GLP-1s are believed to dampen dopamine signaling, which might actually put the lid on initiative and drive and competitiveness, Ziyad Al-Aly, a researcher at Washington University in St
Low blood pressure, or hypotension, is generally defined as a systolic blood pressure below 90 mmHg or diastolic pressure below 60 mmHg, though symptoms matter more than absolute numbers
Several contenders are already in development, as pharmaceutical companies race to find better drugs for weight loss